SCHEMBL4344092

SCHEMBL4344092

O=C(/C=C/c1c[nH]c2ncccc12)NCc1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.51
▸ GSK3B P49841 4/20 0.50
▸ GAA P10253 1/20 0.49
▸ LMNA P02545 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ PLAU P00749 1/20 0.47
▸ GABRP O00591 1/20 0.47
▸ GABRD O14764 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ GABRB1 P18505 1/20 0.47
▸ GABRG2 P18507 1/20 0.47
▸ GABRB3 P28472 1/20 0.47
▸ GABRA5 P31644 1/20 0.47
▸ GABRA3 P34903 1/20 0.47
▸ GABRA2 P47869 1/20 0.47
▸ GABRB2 P47870 1/20 0.47
▸ GABRA4 P48169 1/20 0.47
▸ GABRE P78334 1/20 0.47
▸ GABRA6 Q16445 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4344099 1.00 NPSR1 (0.51) NPSR1GSK3BGAALMNAHTT
SCHEMBL4346706 0.88 SMN1; SMN2 (0.52) NPSR1GSK3BLMNAHTTPLAU
SCHEMBL4346697 0.88 SMN1; SMN2 (0.52) NPSR1GSK3BLMNAHTTPLAU
SCHEMBL4353164 0.87 CDC7 (0.51) GSK3BKMT2ARPS6KB1HDAC1ADORA2A
SCHEMBL4353161 0.87 CDC7 (0.51) GSK3BKMT2ARPS6KB1HDAC1ADORA2A
SCHEMBL4346216 0.87 GSK3B (0.58) GSK3BLMNAKMT2APOLBALDH1A1
SCHEMBL4346212 0.87 GSK3B (0.58) GSK3BLMNAKMT2APOLBALDH1A1
SCHEMBL4355610 0.85 PDPK1 (0.50) GSK3BKMT2APDPK1HDAC1HDAC6
SCHEMBL4355602 0.85 PDPK1 (0.50) GSK3BKMT2APDPK1HDAC1HDAC6
SCHEMBL4350176 0.85 FGFR1 (0.56) GSK3BGAALMNAHTTGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP claimed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP disclosed
Send feedback